(PubMed) Zheng Y, Li Y, Rimm EB, et al
They are not for human consumption, medical, veterinary, or household use
In-vitro studies do not show efficacy of a product in actual human beings, and just because a cell study showed more GLP-1 production doesnt mean that this will happen in a person and have the desired results in terms of weight
The question remains: are we witnessing the peak of obesity-driven M&A, or is this just the beginning of a decade-long race for dominance
Nonetheless, ePA ensures that, when coverage is allowed, a patients initiation onto therapy is not prevented by paperwork, potentially capturing the drugs value